Skip to main content

Table 2 Background clinical data and characteristics of each group

From: Modified A-DROP score and mortality in hemodialysis patients with pneumonia

Severity of pneumonia

Modified

 

Modified

 

Modified

  
 

A-DROP

 

A-DROP

 

A-DROP

  
 

0, 1

 

2

 

3, 4

  
 

n = 27

 

n = 22

 

n = 15

 

p value

Age (years)

65

37–81

76

59–88

81

74–88

<0.001***

Male (n, %)

16

59.3

19

86.4

12

80.0

0.09

BMI (kg/m2)

20.7

16.1–40.9

19.4

14.3–26.3

20.4

14.8–23.9

0.66

Duration of HD (months)

47

3–231

37

2–290

48

1–154

0.97

Cause of HD

 DMN (n, %)

8

29.7

12

54.6

7

46.7

0.20

 Chronic GN (n, %)

10

37.0

6

27.3

5

33.3

0.75

 Nephrosclerosis (n, %)

5

18.5

2

9.1

3

20.0

0.62

 RPGN (n, %)

3

11.1

1

4.5

0

0

0.54

 Other (n, %)

1

3.7

1

4.5

0

0

1.00

Vascular access

 AVF (n, %)

21

77.8

13

59.1

8

53.3

0.21

 AVG (n, %)

3

11.1

8

36.4

4

26.7

0.10

 Catheter (n, %)

3

11.1

1

4.5

3

20.0

0.40

Comorbidity

 CVD (n, %)

13

48.1

10

45.5

11

73.3

0.23

 Malignancy (n, %)

4

14.8

4

18.2

4

26.7

0.65

 CLD (n, %)

6

22.2

5

22.7

2

13.3

0.85

Vital signs

 Systolic BP (mmHg)

129

88–204

150

97–170

120

68–203

0.18

 Diastolic BP (mmHg)

74

53–103

72

47–141

64

40–99

0.24

 Heart rate (/min)

98

68–142

96

68–136

94

58–130

0.49

 Altered mentality (n, %)

0

0

7

31.8

14

93.3

<0.001***

 Fever (degree)

37.1

35.5–39.6

37.7

35.0–39.3

37.8

36.1–39.3

0.38

 Hypoxia (n, %)

11

40.7

19

86.4

15

100

<0.001***

Blood examination

 Alb (g/dL)

3.1

2.1–4.1

3.3

2.1–4.3

3.0

2.0–3.9

0.39

 BUN (mg/dL)

35.2

13.2–80.7

39.4

12.9–84.5

34.2

13.6–74.3

0.48

 Cr (mg/dL)

5.99

1.48–13.32

5.23

2.10–13.05

5.25

2.65–11.20

0.26

 Na (mEq/L)

138

129–145

140

132–147

140

131–147

0.11

 K (mEq/L)

4.2

3.2-5.9

4.5

3.5–8.2

4.1

2.9–8.4

0.25

 CRP (mg/dL)

7.91

1.21–30.80

9.16

0.85–43.12

9.54

1.37–13.99

0.98

 WBC (/μL)

9600

4220–23100

9910

3130–33520

9580

3600–28910

0.99

 Hb (g/dL)

10.6

4.1–16.5

10.9

7.6–14.4

10.5

7.1–13.5

0.98

 Plt (x 104/μL)

16.2

2.7–50.0

17.6

2.1–31.3

14.4

6.8–72.0

0.88

Bacterial cultures

 Sputum (n, %)

20

74.1

20

90.9

14

93.3

0.22

 Blood (n, %)

17

63.0

20

90.9

10

66.7

0.07

Radiological findings

 Multi-lobar lesion (n, %)

15

55.6

15

68.2

12

80.0

0.26

 Pleural effusion (n, %)

14

51.9

15

68.2

14

93.3

0.012*

Therapy and prognosis

 Success of initial therapy

  (n, %)

21

77.8

17

77.3

8

53.3

0.22

 Duration of antibiotics

  (days)

8

1–43

12

3–36

13

3–36

0.023*

  30-day mortality (n, %)

1

3.7

2

9.1

6

40.0

0.004**

  Hospital mortality (n, %)

1

3.7

3

13.6

7

46.7

0.003**

  1. Data for continuous variables are expressed as median and range, and categorical variables are expressed as number and percentages. Categorical variables were compared using Fisher’s exact probability test, and continuous variables among three groups were compared using the Kruskal–Wallis test. Significant difference are indicated with asterisks (***p < 0.001, **p < 0.01, *p < 0.05)
  2. Alb albumin, AVF arteriovenous fistula, AVG arteriovenous graft, BMI body mass index, BP blood pressure, BUN blood urea nitrogen, CLD chronic lung diseases, Cr creatinine, CRP C-reactive protein, CVD cardiovascular diseases, DMN diabetes mellitus nephropathy, K potassium, Na sodium, GN glomerulonephritis, HD hemodialysis, Hb hemoglobin, Plt platelet, RPGN rapid progressive glomerulonephritis, WBC white blood cell count
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us